Skip to main content

Table 4 Randomized controlled trials of adjuvant radiotherapy versus surgery alone for esophageal squamous cell carcinoma

From: Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?

Studies

Histology

SCC (%)

Treatment

n

MS (months)

5-year OS (%)

P value

Kunath and Fischer [39]

SCC

100

ART 50 to 55 Gy

23

9

 

NS

   

Surgery

21

6

  

Ténière and colleagues [40]

SCC

100

ART 45 to 55 Gy

102

18

19

NS

   

Surgery

119

18

19

 

Fok and colleagues [41]

SCC

100

ART 43 to 53 Gy

42

11

10

NS

   

Surgery

39

22

16

 

Zieren and colleagues [42]

SCC

100

ART 56 Gy

33

 

23a

NS

   

Surgery

35

 

22a

 

Xiao and colleagues [43]

SCC

100

ART 50 to 60 Gy

220

 

41

NS

   

Surgery

275

 

32

 
  1. aThree-year overall survival (OS). ART adjuvant radiotherapy, MS median survival, NS, not significant, SCC squamous cell carcinoma.